Paula Kuo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Low Density Lipoprotein

Immune Response

Top Venues

Cancer research communications

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside, Teresa von Linde, Alexander J Wesolowski, Alberto G Conti, Alexander C Evans, Tarrion Baird, Benjamin I Morris, Nicole E Fletcher, Jie Yang, Edmund Poon, Matthew A Lakins, Masahiro Yamamoto, Neil Brewis, Michelle Morrow, Rahul Roychoudhuri
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. Cancer research communications 4 (8) (2024)
Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside, Teresa von Linde, Alexander J Wesolowski, Alberto G Conti, Alexander C Evans, Tarrion Baird, Benjamin I Morris, Nicole E Fletcher, Jie Yang, Edmund Poon, Matthew A Lakins, Masahiro Yamamoto, Neil Brewis, Michelle Morrow, Rahul Roychoudhuri
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. Cancer research communications 4 (8) (2024)
Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside, Teresa von Linde, Alexander J Wesolowski, Alberto G Conti, Alexander C Evans, Tarrion Baird, Benjamin I Morris, Nicole E Fletcher, Jie Yang, Edmund Poon, Matthew A Lakins, Masahiro Yamamoto, Neil Brewis, Michelle Morrow, Rahul Roychoudhuri
IFN-γ production by functionally reprogrammed Treg cells promotes anti-tumor efficacy of OX40/CD137 bispecific agonist therapy. Cancer research communications (2024)
Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside, Teresa von Linde, Alexander J Wesolowski, Alberto G Conti, Alexander C Evans, Tarrion Baird, Benjamin I Morris, Nicole E Fletcher, Jie Yang, Edmund Poon, Matthew A Lakins, Masahiro Yamamoto, Neil Brewis, Michelle Morrow, Rahul Roychoudhuri
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. Cancer research communications 4 (8) (2024)
Charlotte J Imianowski, Sarah K Whiteside, Teresa Lozano, Alexander C Evans, Jayme D Benson, Christina J F Courreges, Firas Sadiyah, Colleen M Lau, Nordin D Zandhuis, Francis M Grant, Martijn J Schuijs, Panagiota Vardaka, Paula Kuo, Elizabeth J Soilleux, Jie Yang, Joseph C Sun, Tomohiro Kurosaki, Klaus Okkenhaug, Timotheus Y F Halim, Rahul Roychoudhuri
BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis. The Journal of experimental medicine 219 (12) (2022)